PFS
IMVT icon

Prospera Financial Services’s Immunovant IMVT Stock Holding History

Prospera Financial Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,777
Closed -$60K – 928
2022
Q3 		$60K Buy
+10,777
New +$52.7K ﹤0.01% 812
2022
Q2 		– Sell
-9,135
Closed -$50K – 2101
2022
Q1 		$50K Buy
+9,135
New +$56.9K ﹤0.01% 1380
2020
Q4 		– Sell
-1,236
Closed -$43K – 1095
2020
Q3 		$43K Buy
+1,236
New +$37.2K 0.02% 671

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Prospera Financial Services's IMVT Position: Q4 2022 in Review

Prospera Financial Services sold out of Immunovant (IMVT) in Q4 2022, closing a stake of 10,777 shares — an estimated $60K sold.

Prospera Financial Services first reported a position in IMVT in Q3 2020 and held it in 3 quarters. The position peaked at $60K in Q3 2022. 133 funds tracked by Wall St. Rank hold IMVT as of Q4 2022.

  • Prospera Financial Services reported no remaining Immunovant position as of Q4 2022 after selling out during the quarter.
  • Prospera Financial Services sold 10,777 Immunovant shares in Q4 2022, an estimated $60K.
  • Prospera Financial Services first reported a position in Immunovant in Q3 2020 and held it in 3 quarters.
  • Prospera Financial Services's Immunovant position peaked at $60K in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Immunovant as of Q4 2022.

Based on Prospera Financial Services's 13F filing for Q4 2022, filed 8 Feb 2023.